Drug profile · INN
bupropion hydrobromide
APLENZIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bupropion hydrobromide (APLENZIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN bupropion hydrobromide
Brand APLENZIN
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Frequently asked questions
What is bupropion hydrobromide?
bupropion hydrobromide (APLENZIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bupropion hydrobromide?
APLENZIN is a marketed brand name for bupropion hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bupropion hydrobromide?
bupropion hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.